Isodiol International Inc.. Reports Fiscal Q2 2019 Financial Results

Isodiol International Inc..

(CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”-RRB- announces its financial and operational results for its second quarter of fiscal 2019, ended September 30, 2018.   

Second Quarter Highlights include:

Subsequent Events:

“In anticipation of the US Farm bill being finalized,1 and with the potential for an increase in demand for consumer packaged goods (CPG), the business scaled back mass raw ingredient CBD earnings in an effort to improve production and inventory of CPG for 2019,” said CEO of Isodiol, Marcos Agramont.  “While this has impacted our Q2 revenues, the Company believes this move was necessary for long-term, sustainable growth. ”

The unaudited condensed consolidated interim financial Statements and MD&A for the three months ended September 30, 2018 will be filed on SEDAR and available at www.sedar.com.

______________________________

1https://www.reuters.com/article/us-usa-farmbill/farm-bill-deal-very-close-senators-say-idUSKCN1NX2ON 

About Isodiol International Inc..

Isodiol International Inc.. Is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution firm of hemp-based consumer products and solutions.

Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Most recently, the Company received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products, as was declared on April 26, 2018.

Isodiol’s growth strategy involves the development of pharmaceutical and over-the-counter drugs and continued international expansion into Latin America, Asia, and Europe.

Twitter: @Isodiolintlinc

ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director

INVESTOR RELATIONS:
Ir@isodiol.com
604-409-4409

MEDIA CONTACT:
Christopher Hussey
media@isodiol.com

Forward-Looking Information: This news release contains”forward-looking information” within the meaning of applicable securities laws pertaining to statements regarding the firm’s business, products and future of the business ’s business, its product offerings and plans for sales and promotion. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that these expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those mentioned in this news release and the Company may not have the ability to carry out its business plans as anticipated. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that these expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of the release.

The CSE has not reviewed, approved or disapproved the content of the press release.

Isodiol.Logo.jpg

Released at Fri, 30 Nov 2018 13:01:57 +0000

Posted in: News

Comments are closed.